Winton Group LTD Brainstorm Cell Therapeutics Inc. Transaction History

Winton Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Jul 21, 2021	SELL	$3.46 - $7.88 $41,433 - $94,363	-11,975 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$3.99 - $17.73 $341,065 - $1.52 Million	-85,480 Reduced 87.71%	11,975 $54,000
Q3 2020 Oct 30, 2020	SELL	$11.19 - $16.92 $235,348 - $355,861	-21,032 Reduced 17.75%	97,455 $1.65 Million
Q2 2020 Aug 05, 2020	BUY	$4.42 - $12.66 $183,518 - $525,643	41,520 Added 53.95%	118,487 $1.33 Million
Q1 2020 May 11, 2020	BUY	$4.01 - $8.88 $55,494 - $122,890	13,839 Added 21.92%	76,967 $357,000
Q4 2019 Feb 13, 2020	SELL	$3.62 - $4.29 $43,233 - $51,235	-11,943 Reduced 15.91%	63,128 $270,000
Q3 2019 Nov 08, 2019	BUY	$3.54 - $4.48 $265,751 - $336,318	75,071 New	75,071 $293,000

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $69.3M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.